Arjo AB (publ) (ARRJF)
- Previous Close
4.5900 - Open
4.5900 - Bid --
- Ask --
- Day's Range
4.5900 - 4.5900 - 52 Week Range
3.7000 - 4.8500 - Volume
100 - Avg. Volume
14 - Market Cap (intraday)
1.167B - Beta (5Y Monthly) 0.29
- PE Ratio (TTM)
27.00 - EPS (TTM)
0.1700 - Earnings Date --
- Forward Dividend & Yield 0.08 (1.80%)
- Ex-Dividend Date Apr 19, 2024
- 1y Target Est
--
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.
www.arjo.com/int/6,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: ARRJF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ARRJF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ARRJF
Valuation Measures
Market Cap
1.16B
Enterprise Value
1.20B
Trailing P/E
27.47
Forward P/E
18.52
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.23
Price/Book (mrq)
1.68
Enterprise Value/Revenue
0.11
Enterprise Value/EBITDA
0.60
Financial Highlights
Profitability and Income Statement
Profit Margin
4.49%
Return on Assets (ttm)
3.94%
Return on Equity (ttm)
6.32%
Revenue (ttm)
11.1B
Net Income Avi to Common (ttm)
499M
Diluted EPS (ttm)
0.1700
Balance Sheet and Cash Flow
Total Cash (mrq)
802M
Total Debt/Equity (mrq)
67.75%
Levered Free Cash Flow (ttm)
1.38B
Company Insights: ARRJF
ARRJF does not have Company Insights